InsiderFlow

Matthew K Fust

CRNX

Matthew K Fust serves as Director at Crinetics Pharmaceuticals, Inc. (CRNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

9 trades

$4.43M

Net Position

Net Seller

$4.43M

Companies Traded

2

CRNX, ATRA

Active Period

Jul 2021 – Sep 2025

9 total trades

Most Recent

Sell CRNX

Sep 26, 2025 · $716.0K

Matthew K Fust's Insider Trading at Crinetics Pharmaceuticals, Inc. (CRNX)

Buys

0 · $0.00

Sells

8 · $4.17M

Total Shares Bought

0

Total Shares Sold

111,700

CRNX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Sep 26, 2025Sell16,000$44.75$716.0K0
Mar 20, 2024Sell60,000$44.14$2.65M0
Jul 13, 2022Sell5,700$20.96$119.5K0
Nov 1, 2021Sell8,954$25.50$228.3K0
Sep 8, 2021Sell6,046$25.50$154.2K0
Jul 26, 2021Sell5,000$19.59$98.0K0
Jul 19, 2021Sell5,000$19.50$97.5K0
Jul 12, 2021Sell5,000$20.71$103.5K0

Matthew K Fust's Insider Trading at Atara Biotherapeutics, Inc. (ATRA)

Buys

0 · $0.00

Sells

1 · $260.4K

Total Shares Bought

0

Total Shares Sold

13,354

ATRA Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Nov 4, 2021Sell13,354$19.50$260.4K0
Matthew K Fust Insider Trading Activity | Crinetics Pharmaceuticals, Inc. | InsiderFlow